Related Experiment Videos
Polydimethyl Siloxane as an Internal Tamponade for Vitreoretinal Surgery
Rumana N Hussain1, Jayavani Myneni, Theodor Stappler
1St Paul's Eye Unit, Royal Liverpool Hospital, Liverpool, UK.
Summary
Polydimethyl siloxane (Siluron Xtra®) offers effective anatomical success for complex retinal detachments. This silicone oil tamponade shows a lower rate of emulsification complications, making it a viable alternative for long-term use.
Area of Science:
- Ophthalmology
- Retinal Surgery
- Biomaterials
Background:
- Internal tamponade agents are crucial in vitreoretinal surgery for managing complex retinal detachments.
- Silicone oil is a common tamponade, but complications like emulsification can occur, especially with long-term use.
Purpose of the Study:
- To evaluate the efficacy and safety of polydimethyl siloxane (Siluron Xtra®) as an internal tamponade in vitreoretinal procedures.
- To assess anatomical and visual outcomes, as well as perioperative complications, specifically intraocular pressure.
Main Methods:
- Retrospective analysis of 28 patients undergoing vitreoretinal procedures with Siluron Xtra® tamponade between March 2014 and March 2015.
- Inclusion of all vitreoretinal cases, including retinal detachments, trauma, endophthalmitis, and intraocular foreign bodies.
- Audit of procedures and adverse event screening.
Main Results:
- Anatomical success was achieved in 79% of cases post-injection and 58% at 3 months post-removal.
- Complications included elevated intraocular pressure in five patients, requiring medical management, and one case of glaucoma surgery post-trauma.
- Cataract developed in 3/6 phakic patients, and visible emulsification occurred in only one patient.
Conclusions:
- Polydimethyl siloxane (Siluron Xtra®) demonstrates acceptable anatomical success rates for complex retinal detachments, comparable to other low-viscosity silicone oils.
- It presents a lower rate of emulsification-related complications, a significant advantage for long-term tamponade requirements.
- This agent is a promising alternative for managing challenging retinal detachment cases.